We are live on
!
Find out more
Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings
AUM
$43.4B
1-Year Est. Return
51.29%
This Fund
S&P 500
This Quarter
Est. Return
+6.11%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$20B
AUM Growth
+$1.57B
(+8.5%)
Cap. Flow
+$909M
Cap. Flow
% of AUM
4.54%
Top 10 Holdings %
Top 10 Hldgs %
28.15%
Holding
1,579
New
363
Increased
591
Reduced
330
Closed
287
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$183M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$165M |
| 3 |
NVIDIA
NVDA
|
+$113M |
| 4 |
Shopify
SHOP
|
+$111M |
| 5 |
ATS Corp
ATS
|
+$87.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SJR
Shaw Communications Inc.
SJR
|
+$123M |
| 2 |
Cenovus Energy
CVE
|
+$113M |
| 3 |
Johnson & Johnson
JNJ
|
+$73.6M |
| 4 |
B
Barrick Mining
B
|
+$73M |
| 5 |
Costco
COST
|
+$59.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.14% |
| 2 | Technology | 18.74% |
| 3 | Industrials | 13.53% |
| 4 | Energy | 10.54% |
| 5 | Materials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRTX
1126
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $273K | ﹤0.01% |
+87,550
| New | +$260K |
|
|
CBIO
1127
Crescent Biopharma
CBIO
$618M
| $272K | ﹤0.01% |
1,562
-28
| -2% | -$4.7K |
|
1128
Forum Energy Technologies
FET
$927M
| $272K | ﹤0.01% |
+10,618
| New | +$252K |
|
1129
Immunic
IMUX
$226M
| $270K | ﹤0.01% |
10,751
+2,060
| +24% | +$34.5K |
|
1130
Weis Markets
WMK
$1.77B
| $269K | ﹤0.01% |
+4,192
| New | +$305K |
|
1131
CytomX Therapeutics
CTMX
$730M
| $268K | ﹤0.01% |
156,040
+21,731
| +16% | +$36.1K |
|
|
BHR
1132
Braemar Hotels & Resorts
BHR
$139M
| $268K | ﹤0.01% |
66,636
-47,262
| -41% | -$187K |
|
|
TWOU
1133
DELISTED
2U Inc
TWOU
| $265K | ﹤0.01% |
2,194
+502
| +30% | +$66.7K |
|
1134
Selective Insurance
SIGI
$5.59B
| $265K | ﹤0.01% |
+2,757
| New | +$272K |
|
|
MPX
1135
DELISTED
Marine Products Corp
MPX
| $264K | ﹤0.01% |
+15,682
| New | +$232K |
|
1136
Standard Motor Products
SMP
$870M
| $264K | ﹤0.01% |
+7,040
| New | +$257K |
|
1137
Allegiant Air
ALGT
$2.36B
| $264K | ﹤0.01% |
+2,088
| New | +$218K |
|
1138
Shake Shack
SHAK
$2.98B
| $264K | ﹤0.01% |
+3,391
| New | +$218K |
|
|
ESPR
1139
DELISTED
Esperion Therapeutics
ESPR
| $261K | ﹤0.01% |
187,937
-51,602
| -22% | -$72.1K |
|
1140
Quanex
NX
$981M
| $261K | ﹤0.01% |
+9,714
| New | +$216K |
|
|
IVAC
1141
DELISTED
Intevac Inc
IVAC
| $259K | ﹤0.01% |
68,970
+13,859
| +25% | +$74.3K |
|
1142
Identive
INVE
$64.1M
| $258K | ﹤0.01% |
+30,707
| New | +$210K |
|
1143
Smart Sand
SND
$213M
| $257K | ﹤0.01% |
156,817
+48,202
| +44% | +$79.4K |
|
1144
Relmada Therapeutics
RLMD
$507M
| $257K | ﹤0.01% |
104,515
-5,444
| -5% | -$15.1K |
|
1145
Jakks Pacific
JAKK
$294M
| $256K | ﹤0.01% |
+12,828
| New | +$278K |
|
|
ALE
1146
DELISTED
Allete
ALE
| $255K | ﹤0.01% |
+4,401
| New | +$272K |
|
|
MRNS
1147
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $253K | ﹤0.01% |
+23,335
| New | +$200K |
|
|
PFC
1148
DELISTED
Premier Financial Corp. Common Stock
PFC
| $252K | ﹤0.01% |
+15,754
| New | +$259K |
|
|
ILLM
1149
DELISTED
illumin Holdings Inc. Common Shares
ILLM
| $251K | ﹤0.01% |
149,800
+16,100
| +12% | +$25.8K |
|
1150
CNO Financial Group
CNO
$5.07B
| $244K | ﹤0.01% |
+10,323
| New | +$230K |
|
Similar funds
LP
HF
Connor, Clark & Lunn Investment Management (CC&L)'s Q2 2023 Portfolio in Review
As of Q2 2023, Connor, Clark & Lunn Investment Management (CC&L) held 1,579 positions worth $20B, up 8.5% from $18.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Connor, Clark & Lunn Investment Management (CC&L) deployed $909M of net new capital in Q2 2023, opening 363 new positions and adding to 591 existing holdings. Its largest new stake was ATS Corp: 1,941,692 shares worth $89.3M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Cenovus Energy, an estimated $113M trimmed.
- Connor, Clark & Lunn Investment Management (CC&L)'s largest Q2 2023 buy was ATS Corp: 1,941,692 shares worth $89.3M.
- Connor, Clark & Lunn Investment Management (CC&L) added most to Microsoft in Q2 2023, an estimated $183M increase.
- Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q2 2023 reduction was Cenovus Energy, cutting an estimated $113M.
- Connor, Clark & Lunn Investment Management (CC&L) fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $123M.
- Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 28% of its $20B portfolio in Q2 2023.
- Connor, Clark & Lunn Investment Management (CC&L) opened 363 new positions and closed 287 in Q2 2023.
- Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 8.5% quarter-over-quarter to $20B.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2023, filed 10 Aug 2023.